In an interview the British media Bloomberg interviews Pascal Soriot, CEO of AstraZeneca, expresses the importance of China for companies such as their own.
When asked to explain why China is so appealing for AstraZeneca, Pascal Soriot mentions the large number of people in China in need of work and medicine, but also stresses the importance of China on the pharmaceutical market.
“A very important country for us and the entire industry”, says Pascal Soriot.
Source: bloomberg.com
AstraZeneca’s strategic focus on China underscores the immense potential of the Chinese market for pharmaceuticals. By fostering partnerships and investing in local production, they’re poised to meet the country’s healthcare needs effectively. Exciting to see such commitment to innovation and accessibility in healthcare!